Skip to main content
. 2018 May 22;90(21):e1889–e1897. doi: 10.1212/WNL.0000000000005550

Figure 2. CSF Aβ1-42 and crenezumab correlation analysis.

Figure 2

Correlation analysis of change in CSF Aβ1-42 from baseline and crenezumab concentrations in patients receiving low-dose 300 mg SC (circles) and those receiving high-dose 15 mg/kg IV (triangles). Aβ = β-amyloid.